Stefano Gay
Genoa, 16132, Italy
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 24 publications
Low-Dose Versus Standard-Dose Radioiodine Therapy in Differentiated Thyroid Cancer: Focus on Tolerability in a Retrospective Evaluation.
Journal: Pharmaceuticals (Basel, Switzerland)
Published: February 17, 2025
Challenging diagnosis of resistance to thyroid hormone in a patient with COVID-19, pituitary microadenoma and unusual response to octreotide long-acting release test.
Journal: Endocrinology, diabetes & metabolism case reports
Published: December 06, 2023
Efficacy and tolerability of somatostatin analogues according to gender in patients with neuroendocrine tumors.
Journal: Reviews in endocrine & metabolic disorders
Published: November 23, 2023
Case report: Twice-daily tolvaptan dosing regimen in a challenging case of hyponatremia due to SIAD.
Case report: Twice-daily tolvaptan dosing regimen in a challenging case of hyponatremia due to SIAD.
Journal: Frontiers in endocrinology
Published: October 08, 2023
Impact of Vitamin D Deficiency on Tumor Aggressiveness in Neuroendocrine Neoplasms.
Journal: Nutrients
Published: July 31, 2023
Impact of microscopic extrathyroidal extension on differentiated thyroid cancer post-surgical risk of recurrence: a retrospective analysis.
Journal: Journal of endocrinological investigation
Published: September 29, 2022
PD-L1 expression, BRAF and TERT mutation in a cohort of aggressive thyroid cancers: case series from a single-centre experience.
Journal: Journal of endocrinological investigation
Published: August 26, 2022
2-[18F]FDG PET in the Management of Radioiodine Refractory Differentiated Thyroid Cancer in the Era of Thyrosin-Kinases Inhibitors: A Real-Life Retrospective Study.
Journal: Diagnostics (Basel, Switzerland)
Published: January 03, 2022
"Present and future of immunotherapy in Neuroendocrine Tumors".
Journal: Reviews in endocrine & metabolic disorders
Published: March 16, 2021
A comparative cross-sectional study on sleep quality in patients with a history of differentiated thyroid carcinoma and its correlation with quality of life.
Journal: Endocrine
Published: April 28, 2020
Case report: lenvatinib in neoadjuvant setting in a patient affected by invasive poorly differentiated thyroid carcinoma.
Journal: Future oncology (London, England)
Published: August 07, 2019
Last Updated: 09/26/2026